C81.00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Nodular lymphocyte predominant Hodgkin lymphoma, unsp site The 2021 edition of ICD-10-CM C81.00 became effective on October 1, 2020.
| ICD-10 from 2011 - 2016 D47.0 is a billable ICD code used to specify a diagnosis of histiocytic and mast cell tumors of uncertain behavior. A 'billable code' is detailed enough to be used to specify a medical diagnosis. The ICD code D470 is used to code Mastocytoma
This is the American ICD-10-CM version of C81.0 - other international versions of ICD-10 C81.0 may differ. All neoplasms are classified in this chapter, whether they are functionally active or not.
A morphologic finding indicating the presence of histiocytic infiltrates within distended lymph node sinuses. A rare non-neoplastic disorder of unknown etiology characterized by distention of the lymph node sinuses and sinusoidal histiocytic infiltration.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare type of lymphatic cancer. It occurs when lymphocytes, a type of white blood cell in your immune system, behave abnormally. Specifically, NLPHL occurs in B lymphocytes. There are different types of lymphoma: Hodgkin or non-Hodgkin.
ICD-9-CM Diagnosis Code 202.8 : Other malignant lymphomas.
I88. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM I88.
ICD-10 code D72. 820 for Lymphocytosis (symptomatic) is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Non-Hodgkin lymphoma, unspecified, unspecified site C85. 90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C85. 90 became effective on October 1, 2021.
ICD-10 code C85. 90 for Non-Hodgkin lymphoma, unspecified, unspecified site is a medical classification as listed by WHO under the range - Malignant neoplasms .
ICD-10 code C85. 9 for Non-Hodgkin lymphoma, unspecified is a medical classification as listed by WHO under the range - Malignant neoplasms .
9: Fever, unspecified.
L04. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM L04.
Definition. By Mayo Clinic Staff. Lymphocytosis (lim-foe-sie-TOE-sis), or a high lymphocyte count, is an increase in white blood cells called lymphocytes. Lymphocytes help fight off diseases, so it's normal to see a temporary increase after an infection.
Lymphocytosis often results from your immune system fighting off an infection or other disease. White blood cells called lymphocytes increase with these conditions. Lymphocytosis isn't preventable, but it can be treated by addressing what's causing your temporary high lymphocyte count.
Atypical lymphocytes are generally lymphocytes that have been activated to respond to a viral infection or sometimes a bacterial or parasitic infection. A few atypical lymphocytes are probably of little clinical significance.
A mastocytoma or mast cell tumor is a type of round-cell tumor consisting of mast cells. It is found in humans and many animal species, in human medicine it also can refer to an accumulation or nodule of mast cells that resembles a tumor.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D47.0. Click on any term below to browse the alphabetical index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 238.5 was previously used, D47.0 is the appropriate modern ICD10 code.
Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) is a form of lymphoma.
DRG Group #011-013 - Tracheostomy for face, mouth and neck diagnoses with MCC.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code C81.01 and a single ICD9 code, 201.41 is an approximate match for comparison and conversion purposes.
Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL) is a form of lymphoma.
DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with MCC.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code C81.00 and a single ICD9 code, 201.40 is an approximate match for comparison and conversion purposes.